English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 14 August 2024, 21:00 HKT/SGT
Share:
    

Source: Femto Technologies Inc
Femto Technologies Reports Increase in Revenue and Transition to Net Profit for the Second Quarter of 2024

Vancouver, BC, Aug 14, 2024 - (NewMediaWire) - Femto Technologies Inc. (Nasdaq: BCAN) (“Femto” or the “Company”), an integrated software company specializing in female technology, has released its financial results for six-month ended June 30, 2024. Full versions of Femto’s unaudited consolidated interim financial statements and management discussion and analysis for the period, can be found on www.sedarplus.ca.

Q2 2024 Financial Highlights:

- Revenue increased 62% to $405,946 for the three-month period ended June 30, 2024, from $251,047 for the same period in 2023.

- Revenue increased 6% to $714,914 for the six-month period ended June 30, 2024, from $671,682 for the same period in 2023.

- Gross Profit increased to 27% for the three-month period ended June 30, 2024, from 26% for the same period in 2023.

- Gross Profit decreased to 25% for the six-month period ended June 30, 2024, from 57% for the same period in 2023.

- Net Profit was $77,375 for the three-month period ended June 30, 2024 compared with a net loss of $1,147,324 for the same period in 2023.

- Working capital increased to $7,276,931 for June 30, 2024, from $2,441,703 for December 31,2023.

- Total assets increased to $41,390,924 for June 30, 2024, from $36,801,368 for December 31,2023.

- Total shares outstanding as of June 30, 2024, were 11,023,480.

Summary of Quarterly Comparison of Revenue, Gross Profit and Net Loss

 

Q2 2024

Q1 2024

Q4 2023

Q3 2023

Q2 2023

Q1 2023

Q4 2022

Q3 2022

Revenue

$405,946

$308,968

$205,121

$202,058

$251,047

$420,635

$232,186

$227,954

Gross Profit (loss)

$111,308

$65,950

$(56,711)

$72,085

$66,239

$316,943

$96,938

$126,866

Net Profit (loss)

$77,375

$(30,617,317)*

$(15,167,579)**

$(1,439,785)

$(1,147,324)

$(740,433)

$(700,222)

$(325,793)

*Includes change in fair value of derivative warrants liabilities in the amount of $28,977,934.

**Includes impairments of intangible assets and asset under construction in the amount of $13,142,481.

About Femto Technologies Inc.

Femto, previously known as BYND Cannasoft, aims to become a beacon of transformative change in the sphere of female health and wellness. Through proprietary Smart Release Technology and a dedication to creating smart, women-centric products, Femto is establishing new benchmarks in the wellness industry.

Femto is an Israeli-based integrated software company. Femto owns and markets "Benefit CRM", a proprietary customer relationship management (CRM) software product enabling small and medium-sized businesses to optimize their day-to-day business activities such as sales management, personnel management, marketing, call center activities, and asset management.

Femto owns the patent-pending intellectual property for the EZ-G device. This therapeutic device uses proprietary software to regulate the flow of low concentrations of CBD oil, hemp seed oil, and other natural oils into the soft tissues of the female reproductive system to potentially treat a wide variety of women's health issues. The EZ-G device includes technological advancements as a sex toy with a more realistic experience and the prototype utilizes sensors to determine what enhances the users' pleasure. The user can control the device through a Bluetooth app installed on a smartphone or other portable device. The data will be transmitted and received from the device to and from the secure cloud using artificial intelligence (AI). The data is combined with other antonymic user preferences to improve its operation by increasing sexual satisfaction. Commercialization of the EZ-G device is subject to receipt of regulatory approvals.

The devices described in this news release are concept devices that are in the first stage of development and will be subject to testing, experiments and regulatory approvals and therefore there is no certainty that they will eventually be marketed.

For further information please refer to the Company’s new website: www.femtocorp.com and on SEDAR+: www.sedarplus.ca.

Gabi Kabazo
Chief Financial Officer
Tel: (604) 833-6820
e-mail: ir@femtocorp.com

Cautionary Note Regarding Forward-Looking Statements

This press release includes certain statements that may be deemed “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended and under Canadian securities laws. When used in this press release, the words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements.

Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual events or developments may differ materially from those in forward-looking statements. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause the Company’s actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Such statements reflect the Company's current views with respect to future events and are subject to such risks and uncertainties. Many factors could cause actual results to differ materially from the statements made, including future financial performance, unanticipated regulatory requests and delays, final patents approval, and those factors discussed in filings made by the company with the Canadian securities regulatory authorities, including (without limitation) in the company's management's discussion and analysis for the year ended December 31, 2023 and annual information form dated April 2, 2024, which are available under the company's profile at www.sedarplus.ca, and in the Company’s Annual Report on Form 20-F for the year then ended that was filed with the U.S. Securities and Exchange Commission on April 3, 2024. Should one or more of these factors occur, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, or expected. We do not intend and do not assume any obligation to update these forward-looking statements, except as required by law. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Shareholders are cautioned not to put undue reliance on such forward-looking statements.



Topic: Press release summary
Source: Femto Technologies Inc

Sectors: Healthcare & Pharm, Cannabis
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Femto Technologies Inc Related News
July 25, 2024 21:00 HKT/SGT
Femto Pioneering US FemTech to Introduce Flagship Wellness Product at The AVN Expo in Las Vegas
July 22, 2024 21:36 HKT/SGT
BYND CANNASOFT Changes Its Name to Femto Technologies Inc.
July 10, 2024 21:06 HKT/SGT
CEO Periodic Update for 2024 and Review on the Market of the Growing FemTech industry
Apr 8, 2024 20:00 HKT/SGT
BYND Cannasoft Announces RSU Grant
Apr 5, 2024 21:00 HKT/SGT
The $7 Billion CBD Market in 2023 is Focused on Significant Growth in Personal Care
More news >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575